Cancer Nanotechnology
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 5.8 | Q1 | 80.2% | 0.849 | Q1 | 79.2% |
| 2024 | 4.8 | Q1 | 77.3% | 0.763 | Q1 | 76.5% |
| 2023 | 4.5 | Q1 | 73.0% | 0.671 | Q2 | 74.4% |
| 2022 | 5.7 | Q2 | 77.0% | 0.882 | Q1 | 83.3% |
| 2021 | 7.9 | Q1 | 83.2% | 0.921 | Q1 | 84.8% |
| 2020 | — | — | 0.889 | Q1 | 82.5% | |
| 2019 | — | — | 1.299 | Q1 | 90.5% | |
| 2018 | — | — | 1.220 | Q1 | 88.2% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1868-6966
ISSN
1868-6958
country
GBcoverage
2010-2026